The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Chronic Refractory Cough (CRC) Treatment Market Research Report 2025
Synopsis
Chronic refractory cough (CRC) refers to cough that persists after treatment according to guidelines. Among the patients who went to the cough specialist clinic, 20% to 46% had chronic refractory cough, and the quality of life and health of these patients were greatly affected.
The global Chronic Refractory Cough (CRC) Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Chronic Refractory Cough (CRC) Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chronic Refractory Cough (CRC) Treatment.
Report Scope
The Chronic Refractory Cough (CRC) Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Chronic Refractory Cough (CRC) Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Chronic Refractory Cough (CRC) Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck
Nerre Therapeutics
Bellus Health
Attenua
Respivant Sciences
Shionogi
Segment by Type
Speech Therapy
Physiotherapy
Segment by Application
Hospital
Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Chronic Refractory Cough (CRC) Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Chronic refractory cough (CRC) refers to cough that persists after treatment according to guidelines. Among the patients who went to the cough specialist clinic, 20% to 46% had chronic refractory cough, and the quality of life and health of these patients were greatly affected.
The global Chronic Refractory Cough (CRC) Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Chronic Refractory Cough (CRC) Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chronic Refractory Cough (CRC) Treatment.
Report Scope
The Chronic Refractory Cough (CRC) Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Chronic Refractory Cough (CRC) Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Chronic Refractory Cough (CRC) Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck
Nerre Therapeutics
Bellus Health
Attenua
Respivant Sciences
Shionogi
Segment by Type
Speech Therapy
Physiotherapy
Segment by Application
Hospital
Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Chronic Refractory Cough (CRC) Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Chronic Refractory Cough (CRC) Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Speech Therapy
1.2.3 Physiotherapy
1.3 Market by Application
1.3.1 Global Chronic Refractory Cough (CRC) Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Chronic Refractory Cough (CRC) Treatment Market Perspective (2019-2030)
2.2 Chronic Refractory Cough (CRC) Treatment Growth Trends by Region
2.2.1 Global Chronic Refractory Cough (CRC) Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Chronic Refractory Cough (CRC) Treatment Historic Market Size by Region (2019-2024)
2.2.3 Chronic Refractory Cough (CRC) Treatment Forecasted Market Size by Region (2025-2030)
2.3 Chronic Refractory Cough (CRC) Treatment Market Dynamics
2.3.1 Chronic Refractory Cough (CRC) Treatment Industry Trends
2.3.2 Chronic Refractory Cough (CRC) Treatment Market Drivers
2.3.3 Chronic Refractory Cough (CRC) Treatment Market Challenges
2.3.4 Chronic Refractory Cough (CRC) Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Chronic Refractory Cough (CRC) Treatment Players by Revenue
3.1.1 Global Top Chronic Refractory Cough (CRC) Treatment Players by Revenue (2019-2024)
3.1.2 Global Chronic Refractory Cough (CRC) Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Chronic Refractory Cough (CRC) Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Chronic Refractory Cough (CRC) Treatment Revenue
3.4 Global Chronic Refractory Cough (CRC) Treatment Market Concentration Ratio
3.4.1 Global Chronic Refractory Cough (CRC) Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Chronic Refractory Cough (CRC) Treatment Revenue in 2023
3.5 Chronic Refractory Cough (CRC) Treatment Key Players Head office and Area Served
3.6 Key Players Chronic Refractory Cough (CRC) Treatment Product Solution and Service
3.7 Date of Enter into Chronic Refractory Cough (CRC) Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Chronic Refractory Cough (CRC) Treatment Breakdown Data by Type
4.1 Global Chronic Refractory Cough (CRC) Treatment Historic Market Size by Type (2019-2024)
4.2 Global Chronic Refractory Cough (CRC) Treatment Forecasted Market Size by Type (2025-2030)
5 Chronic Refractory Cough (CRC) Treatment Breakdown Data by Application
5.1 Global Chronic Refractory Cough (CRC) Treatment Historic Market Size by Application (2019-2024)
5.2 Global Chronic Refractory Cough (CRC) Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Chronic Refractory Cough (CRC) Treatment Market Size (2019-2030)
6.2 North America Chronic Refractory Cough (CRC) Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Chronic Refractory Cough (CRC) Treatment Market Size by Country (2019-2024)
6.4 North America Chronic Refractory Cough (CRC) Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Chronic Refractory Cough (CRC) Treatment Market Size (2019-2030)
7.2 Europe Chronic Refractory Cough (CRC) Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Chronic Refractory Cough (CRC) Treatment Market Size by Country (2019-2024)
7.4 Europe Chronic Refractory Cough (CRC) Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Chronic Refractory Cough (CRC) Treatment Market Size (2019-2030)
8.2 Asia-Pacific Chronic Refractory Cough (CRC) Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Chronic Refractory Cough (CRC) Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific Chronic Refractory Cough (CRC) Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Chronic Refractory Cough (CRC) Treatment Market Size (2019-2030)
9.2 Latin America Chronic Refractory Cough (CRC) Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Chronic Refractory Cough (CRC) Treatment Market Size by Country (2019-2024)
9.4 Latin America Chronic Refractory Cough (CRC) Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Chronic Refractory Cough (CRC) Treatment Market Size (2019-2030)
10.2 Middle East & Africa Chronic Refractory Cough (CRC) Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Chronic Refractory Cough (CRC) Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa Chronic Refractory Cough (CRC) Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Detail
11.1.2 Merck Business Overview
11.1.3 Merck Chronic Refractory Cough (CRC) Treatment Introduction
11.1.4 Merck Revenue in Chronic Refractory Cough (CRC) Treatment Business (2019-2024)
11.1.5 Merck Recent Development
11.2 Nerre Therapeutics
11.2.1 Nerre Therapeutics Company Detail
11.2.2 Nerre Therapeutics Business Overview
11.2.3 Nerre Therapeutics Chronic Refractory Cough (CRC) Treatment Introduction
11.2.4 Nerre Therapeutics Revenue in Chronic Refractory Cough (CRC) Treatment Business (2019-2024)
11.2.5 Nerre Therapeutics Recent Development
11.3 Bellus Health
11.3.1 Bellus Health Company Detail
11.3.2 Bellus Health Business Overview
11.3.3 Bellus Health Chronic Refractory Cough (CRC) Treatment Introduction
11.3.4 Bellus Health Revenue in Chronic Refractory Cough (CRC) Treatment Business (2019-2024)
11.3.5 Bellus Health Recent Development
11.4 Attenua
11.4.1 Attenua Company Detail
11.4.2 Attenua Business Overview
11.4.3 Attenua Chronic Refractory Cough (CRC) Treatment Introduction
11.4.4 Attenua Revenue in Chronic Refractory Cough (CRC) Treatment Business (2019-2024)
11.4.5 Attenua Recent Development
11.5 Respivant Sciences
11.5.1 Respivant Sciences Company Detail
11.5.2 Respivant Sciences Business Overview
11.5.3 Respivant Sciences Chronic Refractory Cough (CRC) Treatment Introduction
11.5.4 Respivant Sciences Revenue in Chronic Refractory Cough (CRC) Treatment Business (2019-2024)
11.5.5 Respivant Sciences Recent Development
11.6 Shionogi
11.6.1 Shionogi Company Detail
11.6.2 Shionogi Business Overview
11.6.3 Shionogi Chronic Refractory Cough (CRC) Treatment Introduction
11.6.4 Shionogi Revenue in Chronic Refractory Cough (CRC) Treatment Business (2019-2024)
11.6.5 Shionogi Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Chronic Refractory Cough (CRC) Treatment Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Speech Therapy
Table 3. Key Players of Physiotherapy
Table 4. Global Chronic Refractory Cough (CRC) Treatment Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Chronic Refractory Cough (CRC) Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Chronic Refractory Cough (CRC) Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Chronic Refractory Cough (CRC) Treatment Market Share by Region (2019-2024)
Table 8. Global Chronic Refractory Cough (CRC) Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Chronic Refractory Cough (CRC) Treatment Market Share by Region (2025-2030)
Table 10. Chronic Refractory Cough (CRC) Treatment Market Trends
Table 11. Chronic Refractory Cough (CRC) Treatment Market Drivers
Table 12. Chronic Refractory Cough (CRC) Treatment Market Challenges
Table 13. Chronic Refractory Cough (CRC) Treatment Market Restraints
Table 14. Global Chronic Refractory Cough (CRC) Treatment Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Chronic Refractory Cough (CRC) Treatment Market Share by Players (2019-2024)
Table 16. Global Top Chronic Refractory Cough (CRC) Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Refractory Cough (CRC) Treatment as of 2023)
Table 17. Ranking of Global Top Chronic Refractory Cough (CRC) Treatment Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Chronic Refractory Cough (CRC) Treatment Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Chronic Refractory Cough (CRC) Treatment Product Solution and Service
Table 21. Date of Enter into Chronic Refractory Cough (CRC) Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Chronic Refractory Cough (CRC) Treatment Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Chronic Refractory Cough (CRC) Treatment Revenue Market Share by Type (2019-2024)
Table 25. Global Chronic Refractory Cough (CRC) Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Chronic Refractory Cough (CRC) Treatment Revenue Market Share by Type (2025-2030)
Table 27. Global Chronic Refractory Cough (CRC) Treatment Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Chronic Refractory Cough (CRC) Treatment Revenue Market Share by Application (2019-2024)
Table 29. Global Chronic Refractory Cough (CRC) Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Chronic Refractory Cough (CRC) Treatment Revenue Market Share by Application (2025-2030)
Table 31. North America Chronic Refractory Cough (CRC) Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Chronic Refractory Cough (CRC) Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Chronic Refractory Cough (CRC) Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Chronic Refractory Cough (CRC) Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Chronic Refractory Cough (CRC) Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Chronic Refractory Cough (CRC) Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Chronic Refractory Cough (CRC) Treatment Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Chronic Refractory Cough (CRC) Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Chronic Refractory Cough (CRC) Treatment Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Chronic Refractory Cough (CRC) Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Chronic Refractory Cough (CRC) Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Chronic Refractory Cough (CRC) Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Chronic Refractory Cough (CRC) Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Chronic Refractory Cough (CRC) Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Chronic Refractory Cough (CRC) Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 46. Merck Company Detail
Table 47. Merck Business Overview
Table 48. Merck Chronic Refractory Cough (CRC) Treatment Product
Table 49. Merck Revenue in Chronic Refractory Cough (CRC) Treatment Business (2019-2024) & (US$ Million)
Table 50. Merck Recent Development
Table 51. Nerre Therapeutics Company Detail
Table 52. Nerre Therapeutics Business Overview
Table 53. Nerre Therapeutics Chronic Refractory Cough (CRC) Treatment Product
Table 54. Nerre Therapeutics Revenue in Chronic Refractory Cough (CRC) Treatment Business (2019-2024) & (US$ Million)
Table 55. Nerre Therapeutics Recent Development
Table 56. Bellus Health Company Detail
Table 57. Bellus Health Business Overview
Table 58. Bellus Health Chronic Refractory Cough (CRC) Treatment Product
Table 59. Bellus Health Revenue in Chronic Refractory Cough (CRC) Treatment Business (2019-2024) & (US$ Million)
Table 60. Bellus Health Recent Development
Table 61. Attenua Company Detail
Table 62. Attenua Business Overview
Table 63. Attenua Chronic Refractory Cough (CRC) Treatment Product
Table 64. Attenua Revenue in Chronic Refractory Cough (CRC) Treatment Business (2019-2024) & (US$ Million)
Table 65. Attenua Recent Development
Table 66. Respivant Sciences Company Detail
Table 67. Respivant Sciences Business Overview
Table 68. Respivant Sciences Chronic Refractory Cough (CRC) Treatment Product
Table 69. Respivant Sciences Revenue in Chronic Refractory Cough (CRC) Treatment Business (2019-2024) & (US$ Million)
Table 70. Respivant Sciences Recent Development
Table 71. Shionogi Company Detail
Table 72. Shionogi Business Overview
Table 73. Shionogi Chronic Refractory Cough (CRC) Treatment Product
Table 74. Shionogi Revenue in Chronic Refractory Cough (CRC) Treatment Business (2019-2024) & (US$ Million)
Table 75. Shionogi Recent Development
Table 76. Research Programs/Design for This Report
Table 77. Key Data Information from Secondary Sources
Table 78. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Chronic Refractory Cough (CRC) Treatment Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Chronic Refractory Cough (CRC) Treatment Market Share by Type: 2023 VS 2030
Figure 3. Speech Therapy Features
Figure 4. Physiotherapy Features
Figure 5. Global Chronic Refractory Cough (CRC) Treatment Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Chronic Refractory Cough (CRC) Treatment Market Share by Application: 2023 VS 2030
Figure 7. Hospital Case Studies
Figure 8. Clinic Case Studies
Figure 9. Others Case Studies
Figure 10. Chronic Refractory Cough (CRC) Treatment Report Years Considered
Figure 11. Global Chronic Refractory Cough (CRC) Treatment Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Chronic Refractory Cough (CRC) Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Chronic Refractory Cough (CRC) Treatment Market Share by Region: 2023 VS 2030
Figure 14. Global Chronic Refractory Cough (CRC) Treatment Market Share by Players in 2023
Figure 15. Global Top Chronic Refractory Cough (CRC) Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Refractory Cough (CRC) Treatment as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Chronic Refractory Cough (CRC) Treatment Revenue in 2023
Figure 17. North America Chronic Refractory Cough (CRC) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Chronic Refractory Cough (CRC) Treatment Market Share by Country (2019-2030)
Figure 19. United States Chronic Refractory Cough (CRC) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada Chronic Refractory Cough (CRC) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Chronic Refractory Cough (CRC) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Chronic Refractory Cough (CRC) Treatment Market Share by Country (2019-2030)
Figure 23. Germany Chronic Refractory Cough (CRC) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France Chronic Refractory Cough (CRC) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. Chronic Refractory Cough (CRC) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy Chronic Refractory Cough (CRC) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia Chronic Refractory Cough (CRC) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries Chronic Refractory Cough (CRC) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Chronic Refractory Cough (CRC) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Chronic Refractory Cough (CRC) Treatment Market Share by Region (2019-2030)
Figure 31. China Chronic Refractory Cough (CRC) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan Chronic Refractory Cough (CRC) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea Chronic Refractory Cough (CRC) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia Chronic Refractory Cough (CRC) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India Chronic Refractory Cough (CRC) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia Chronic Refractory Cough (CRC) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Chronic Refractory Cough (CRC) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Chronic Refractory Cough (CRC) Treatment Market Share by Country (2019-2030)
Figure 39. Mexico Chronic Refractory Cough (CRC) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil Chronic Refractory Cough (CRC) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Chronic Refractory Cough (CRC) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Chronic Refractory Cough (CRC) Treatment Market Share by Country (2019-2030)
Figure 43. Turkey Chronic Refractory Cough (CRC) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia Chronic Refractory Cough (CRC) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Merck Revenue Growth Rate in Chronic Refractory Cough (CRC) Treatment Business (2019-2024)
Figure 46. Nerre Therapeutics Revenue Growth Rate in Chronic Refractory Cough (CRC) Treatment Business (2019-2024)
Figure 47. Bellus Health Revenue Growth Rate in Chronic Refractory Cough (CRC) Treatment Business (2019-2024)
Figure 48. Attenua Revenue Growth Rate in Chronic Refractory Cough (CRC) Treatment Business (2019-2024)
Figure 49. Respivant Sciences Revenue Growth Rate in Chronic Refractory Cough (CRC) Treatment Business (2019-2024)
Figure 50. Shionogi Revenue Growth Rate in Chronic Refractory Cough (CRC) Treatment Business (2019-2024)
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
